Current Experimental Studies of Gene Therapy in Parkinson's Disease
Parkinson's disease (PD) was characterized by late-onset, progressive dopamine neuron loss and movement disorders. The progresses of PD affected the neural function and integrity. To date, most researches had largely addressed the dopamine replacement therapies, but the appearance of L-dopa-ind...
Main Authors: | Jing-ya Lin, Cheng-long Xie, Su-fang Zhang, Weien Yuan, Zhen-Guo Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnagi.2017.00126/full |
Similar Items
-
Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
by: Gonzalo S. Nido, et al.
Published: (2020-04-01) -
Gene-Based Therapeutics for Parkinson’s Disease
by: Karim E. Shalaby, et al.
Published: (2022-07-01) -
Neuroinflammation in Parkinson’s Disease – Putative Pathomechanisms and Targets for Disease-Modification
by: Alexander Grotemeyer, et al.
Published: (2022-05-01) -
Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
by: Sandra Barata-Antunes, et al.
Published: (2020-05-01) -
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
by: Xian-Si Zeng, et al.
Published: (2018-04-01)